Epiminder Announces Appointment of Mark McLellan as Chief Financial Officer
Epiminder Limited, a pioneering medical device company developing breakthrough epilepsy monitoring technology, today announced the appointment of Mark McLellan as Chief Financial Officer. McLellan brings extensive experience in healthcare finance and strategic leadership to support Epiminder's rapid growth following the recent FDA authorization of its Minder® implantable continuous EEG monitoring (iCEM®) system.
